No segmentation disclosed for this filer. n/a
Lattice Biologics Ltd. booked $2.5M in FY2020 revenue, growing 13% year over year — about the middle of the pack among Healthcare companies we track, at a -60.2% net margin.
No filings loaded — no CIK (non-SEC filer).